The use of anti-CD112R mAbs in a CD112+ and CD155+ human breast cancer cell line enhanced NK cell cytokine production and degranulation, confirming the inhibitory functions of CD112R [20,130]. This evidence concerns the gene PVRIG and breast cancer.